Tumor-initiating stem cells engineer immunity
Cancer Cell · 2026
DOI: 10.1016/j.ccell.2025.10.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2026. Verfasst von Zhe Yang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Stowers Institute for Medical Research, Kansas City, MO 64110, USA. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: Stowers Institute for Medical Research.
Abstract (Originalsprache)
Immunotherapy reshapes the interaction between the tumor microenvironment and cancer stem cells. In this issue of Cancer Cell, Guo et al. revealed that SOX2High tumor-initiating stem cells reprogram neutrophils that block interferon-induced reprogramming after immunotherapy, maintaining their pro-tumor phenotype at the tumor-stroma interface.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Stowers Institute for Medical Research, Kansas City, MO 64110, USA.
- Stowers Institute for Medical Research, Kansas City, MO 64110, USA; Department of Pathology and Laboratory Medicine and Division of Medical Oncology, Internal Medicine, University of Kansas Medical Center, Kansas City,…
Förderung
- Stowers Institute for Medical Research
Zitieren
APA
Yang, Z., & Li, L. (2026). Tumor-initiating stem cells engineer immunity. Cancer Cell. https://doi.org/10.1016/j.ccell.2025.10.012
Vancouver
Yang Z, Li L. Tumor-initiating stem cells engineer immunity. Cancer Cell. 2026. doi:10.1016/j.ccell.2025.10.012
BibTeX
@article{Yang2026,
author = {Yang, Zhe and Li, Linheng},
title = {Tumor-initiating stem cells engineer immunity},
journal = {Cancer Cell},
year = {2026},
doi = {10.1016/j.ccell.2025.10.012}
}
EUVIMED